References
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Available at: http://www.goldcopd.org
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775–789
Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 361:449–456
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borrill, Z., Roy, K., Kolsum, U. et al. Seretide withdrawal increases airway inflammation in moderate COPD patients. Eur J Clin Pharmacol 65, 1165–1166 (2009). https://doi.org/10.1007/s00228-009-0697-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0697-5